Enregistrement - Lobbyistes-conseils

Objets

• Commerce intérieur
• Commerce international
• Industrie
• Propriété intellectuelle
• Questions touchant les consommateurs
• Santé
• Sciences et technologies

Détails sur l'objet

Politique ou Programme

• National Pharmaceuticals Strategy, particularly with respect to Health Canada policies and programs on catastrophic drug coverage, common formulary, pricing and purchasing strategies, and expensive drugs for rare diseases
• Patented Medicines Prices Review Board with respect to decisions on the reporting obligations of patented drug products patentees and guidelines for the regulation of pricing of patented drug products
• Science and Technology Strategy led by Industry Canada, particularly with respect to the life sciences priority under the S&T Strategy

Proposition législative, Projet de loi ou résolution

• Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
• Patent Act as it relates to the regulation of intellectual property for therapeutic products
• Patent Act with respect to Canada's Access to Medicines Regime (ss. 21.01-21.09)

Règlement

• Food and Drugs Act Regulations with respect to Data Protection under C.08.004.
• Food and Drugs Act Regulations, specifically with respect to approval, regulation and life-cycle management of therapeutic products
• Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products and the Patented Medicines (Notice of Compliance) Regulations

Techniques de communication

• Communication écrite
• Communication orale

Institutions gouvernementales

• Affaires étrangères, Commerce international et Développement
• Chambre des communes
• Conseil d'examen du prix des médicaments brevetés (CEPMB)
• Industrie Canada
• Santé Canada (SC)
• Sénat du Canada

Adresse :
55 Metcalfe Street - Suite 1220
Ottawa, ON  K1P 6L5
Canada

Numéro de téléphone : 613-236-0455

Représentant du client

Keith McIntosh, Executive Director, Executive Director, Scientific & Regulatory Affairs

Renseignements sur la société mère

Rx&D, Les compagnies de recherche pharmaceutique du Canada / Rx&D, Canada's Research-Based Pharmaceutical Companies n'est pas une filiale d'une société mère.